Excerpt from a 2013 Duff and Phelps report on the valuation in the health care sector
The current median LTM revenue and LTM EBITDA multiples for the Pharmaceutical / Medical Device / Life Science industry overall are 2.1x and 10.7x, respectively.••The sectors with the highest valuation multiples include: >>Biotechnology (4.1x LTM Revenue, 11.3x LTM EBITDA)>>Surgical Devices (1.5x LTM Revenue, 19.3x LTM EBITDA)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.